UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by Sandbox Financial Partners LLC

Sandbox Financial Partners LLC raised its position in UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 2.1% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 1,032 shares of the healthcare conglomerate’s stock after acquiring an additional 21 shares during the quarter. Sandbox Financial Partners LLC’s holdings in UnitedHealth Group were worth $543,000 as of its most recent filing with the SEC.

Several other institutional investors also recently bought and sold shares of the company. Richelieu Gestion SA purchased a new stake in shares of UnitedHealth Group during the 4th quarter worth $26,000. Robbins Farley acquired a new position in shares of UnitedHealth Group during the 3rd quarter valued at about $25,000. CGC Financial Services LLC increased its stake in shares of UnitedHealth Group by 1,000.0% during the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after acquiring an additional 50 shares during the last quarter. NewSquare Capital LLC increased its position in UnitedHealth Group by 340.0% during the 3rd quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock worth $33,000 after purchasing an additional 51 shares in the last quarter. Finally, Strategic Investment Solutions Inc. IL acquired a new stake in UnitedHealth Group during the 1st quarter worth approximately $35,000. 87.86% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on UNH shares. Barclays began coverage on shares of UnitedHealth Group in a research report on Wednesday, March 6th. They set an “overweight” rating and a $551.00 target price for the company. Stephens reiterated an “overweight” rating and set a $605.00 target price on shares of UnitedHealth Group in a research note on Thursday, February 8th. Truist Financial reiterated a “buy” rating and set a $610.00 target price on shares of UnitedHealth Group in a research note on Thursday, November 30th. Oppenheimer reiterated an “outperform” rating and set a $610.00 target price on shares of UnitedHealth Group in a research note on Wednesday, January 17th. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $591.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 19th. One analyst has rated the stock with a sell rating, two have issued a hold rating, fifteen have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus target price of $579.33.

View Our Latest Stock Report on UnitedHealth Group

Insider Activity at UnitedHealth Group

In related news, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the sale, the executive vice president now directly owns 9,364 shares in the company, valued at $4,527,306.72. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In related news, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares in the company, valued at approximately $4,527,306.72. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the sale, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by company insiders.

UnitedHealth Group Stock Performance

UNH traded up $1.60 during trading on Thursday, reaching $494.70. 3,805,551 shares of the company’s stock were exchanged, compared to its average volume of 4,097,774. The company has a market capitalization of $456.08 billion, a P/E ratio of 20.70, a PEG ratio of 1.34 and a beta of 0.54. The business has a 50 day moving average price of $503.10 and a 200 day moving average price of $518.61. UnitedHealth Group Incorporated has a fifty-two week low of $445.68 and a fifty-two week high of $554.70. The company has a quick ratio of 0.79, a current ratio of 0.79 and a debt-to-equity ratio of 0.62.

UnitedHealth Group (NYSE:UNHGet Free Report) last issued its quarterly earnings data on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.98 by $0.18. The company had revenue of $94.43 billion during the quarter, compared to analysts’ expectations of $92.13 billion. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. The business’s revenue was up 14.1% on a year-over-year basis. During the same period last year, the business earned $5.34 earnings per share. As a group, analysts predict that UnitedHealth Group Incorporated will post 27.82 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were issued a $1.88 dividend. The ex-dividend date was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.52%. UnitedHealth Group’s dividend payout ratio is 31.54%.

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Further Reading

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.